financetom
Business
financetom
/
Business
/
Fastenal Insider Sold Shares Worth $1,588,315, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Fastenal Insider Sold Shares Worth $1,588,315, According to a Recent SEC Filing
Nov 9, 2024 1:36 PM

05:08 PM EST, 11/08/2024 (MT Newswires) -- John Lewis Soderberg, Senior Executive Vice President, on November 06, 2024, sold 19,148 shares in Fastenal ( FAST ) for $1,588,315. Following the Form 4 filing with the SEC, Soderberg has control over a total of 14,941 shares of the company, with 14,941 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/815556/000141588924026461/xslF345X05/form4-11082024_101127.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
US charges former Wamco co-CIO Kenneth Leech with fraud
US charges former Wamco co-CIO Kenneth Leech with fraud
Nov 25, 2024
NEW YORK, Nov 25 (Reuters) - Kenneth Leech, the former co-chief investment officer of Western Asset Management Co, was charged by U.S. authorities on Monday with running a fraudulent cherry-picking scheme where he improperly favored some clients' accounts over others when allocating trades. The U.S. Securities and Exchange Commission said that between January 2021 and October 2023, Leech disproportionately allocated...
New Jersey Resources Fiscal Q4 EPS, Revenue Rise; Sells Solar Portfolio for $132.5 Million
New Jersey Resources Fiscal Q4 EPS, Revenue Rise; Sells Solar Portfolio for $132.5 Million
Nov 25, 2024
05:20 PM EST, 11/25/2024 (MT Newswires) -- New Jersey Resources ( NJR ) reported fiscal Q4 earnings late Monday of $0.91 per diluted share, up from $0.38 a year earlier. Analysts polled by FactSet, on average, expected $0.88. Revenue for the quarter ended Sept. 30 was $395.8 million, compared with $331.3 million a year earlier. One Analyst expected $407 million....
What's Going On With Hims & Hers Health Stock Monday?
What's Going On With Hims & Hers Health Stock Monday?
Nov 25, 2024
Shares of Hims & Hers Health, Inc. ( HIMS ) traded higher on Monday in response to President-elect Donald Trump’s plans to nominate Marty Makary to lead the Food and Drug Administration (FDA). Here’s what you need to know. What To Know: Market optimism surrounding Makary's selection may have bolstered Hims & Hers shares on Monday as investors anticipate that...
Zimmer Biomet Gets FDA Approval for Cementless Partial Knee Implant
Zimmer Biomet Gets FDA Approval for Cementless Partial Knee Implant
Nov 25, 2024
04:46 PM EST, 11/25/2024 (MT Newswires) -- Zimmer Biomet Holdings ( ZBH ) said Monday the US Food and Drug Administration approved a premarket approval application supplement for the Oxford cementless partial knee implant. The regulatory approval is based on safety and effectiveness results from an investigational device exemption study as well as non-clinical testing for cementless partial knee replacement,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved